Peripheral/Endo

Endologix Announces Collaboration Agreements with Japan Lifeline for the Development and Commercialization of Thoracic Endovascular Systems in Japan

IRVINE, Calif.–(BUSINESS WIRE)–Endologix, Inc. (NASDAQ: ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced that it has signed a joint research and development agreement, as well as an exclusive distribution agreement, with Japan Lifeline Co., Ltd. (“JLL”) pertaining to the development and distribution of novel endovascular […]

VENITI, Inc. Announces Boston Scientific Distribution Agreement For VICI VENOUS STENT®

FREMONT, Calif. and ST. LOUIS, Sept. 11, 2017 /PRNewswire/ — VENITI®, Inc., a leader in the advancement of treatment for deep venous disease, today announced that Boston Scientific will distribute the VICI VENOUS STENT under a limited global distribution agreement. The terms of the agreement and specific regions and countries involved were not disclosed.  Launched […]

Medtronic (MDT) Announces Japanese Regulatory Approval For The IN.PACT Admiral Drug-Coated Balloon

DUBLIN – September 8, 2017 – Medtronic plc (NYSE: MDT) today announced that the IN.PACT(TM)Admiral(TM) Drug-Coated Balloon (DCB) received approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) for the treatment of peripheral artery disease (PAD) in the upper leg – specifically, in the thigh (superficial femoral arteries (SFA)) and […]

VentureMed Group Appoints New VP Of Sales And Marketing

TOLEDO, Ohio, Sept. 5, 2017 /PRNewswire/ — VentureMed Group, Inc., (“VMG” or the “Company”) a medical device company focused on developing and commercializing next-generation endovascular devices to treat peripheral arterial disease (PAD), announced today the appointment of Dave Cox as Vice President of Sales and Marketing. In this role, Mr. Cox will be responsible for […]

Gardia Medical Demonstrates Enhanced Safety in Lower Extremity Interventions

CAESAREA, Israel, Sept. 6, 2017 /PRNewswire/ — Gardia Medical, an Israeli Medical Device Company focused on embolic protection solutions, announced that according to the independent Clinical Events Committee (CEC), Gardia successfully met the primary end-point in its WISE-LE study. The WISE-LE study’s objective is to demonstrate the safety and performance of the […]

Spectranetics Recalls Bridge Occlusion Balloons

Philips subsidiary Spectranetics recalls Bridge occlusion balloon AUGUST 31, 2017 BY BRAD PERRIELLO , MassDevice Royal Philips (NYSE:PHG) subsidiary Spectranetics recalled its Bridge occlusion balloon after receiving reports of blocked guidewire lumens. The Bridge device is used to temporarily block the superior vena cava for emergency control of hemorrhage. Spectranetics said the August 25 recall was […]

PQ Bypass Earns Frost & Sullivan’s European Technology Innovation Award for Its Proprietary DETOUR System for Percutaneous Bypass

LONDON, Aug. 31, 2017 /PRNewswire/ — Frost & Sullivan is pleased to recognize PQ Bypass with the 2017 European PAD Interventions Technology Innovation Award. PQ Bypass’ DETOUR System is a minimally invasive technology that enables physicians to re-direct, or detour, blood flow around extremely long blockages in the upper leg arteries to restore […]